What is the ICD-10 (International Classification of Diseases, 10th Revision) code for propranolol (a non-selective beta-blocker) use in anxiety disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

The ICD-10 code for propranolol use in anxiety is F41.9 (Anxiety disorder, unspecified) combined with Z79.899 (Other long term (current) drug therapy). Propranolol is a beta-blocker commonly prescribed off-label for situational or performance anxiety at doses ranging from 10-40mg taken 30-60 minutes before anxiety-provoking events. For ongoing anxiety management, dosing typically ranges from 10-20mg two to three times daily. When documenting this treatment, it's essential to note both the underlying anxiety condition and the medication being used. Propranolol works by blocking the physical symptoms of anxiety (such as rapid heartbeat, trembling, and sweating) by preventing adrenaline from binding to beta receptors. While not FDA-approved specifically for anxiety disorders, propranolol is particularly effective for performance anxiety where physical symptoms are prominent.

Key Considerations

  • Patients should be monitored for potential side effects including fatigue, dizziness, and bradycardia, and the medication should be used cautiously in patients with asthma, diabetes, or certain heart conditions.
  • The most recent and highest quality study, 1, found no evidence for a beneficial effect of beta-blockers compared with either placebo or benzodiazepines in patients with social phobia or panic disorder with/without agoraphobia.
  • Despite the lack of robust evidence, propranolol may still be prescribed off-label for anxiety, particularly for performance anxiety, as noted in 2 and 3.
  • It is crucial to weigh the potential benefits and risks of propranolol use in anxiety disorders, considering the limited evidence and potential side effects, as discussed in 4 and 3.

References

Research

Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis.

Journal of psychopharmacology (Oxford, England), 2016

Research

[Social anxiety and propranolol abuse: a case study].

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.